Matthieu Leuillier
Rouen, 76000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary Hypertension.
Journal: Comprehensive Physiology
Published: August 16, 2025
Expression of placental CD146 is dysregulated by prenatal alcohol exposure and contributes in cortical vasculature development and positioning of vessel-associated oligodendrocytes.
Journal: Frontiers in cellular neuroscience
Published: September 15, 2023
CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury.
Journal: Journal of advanced research
Published: December 15, 2021
Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.
Journal: Journal of medicinal chemistry
Published: August 23, 2019
Beneficial Effects of Remifentanil Against Excitotoxic Brain Damage in Newborn Mice.
Journal: Frontiers in neurology
Published: January 18, 2019
Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.
Journal: Cardiovascular diabetology
Published: January 09, 2019
Multiple and Opposite Effects of Angiotensin II Receptor Blockers on the Bioavailability of Epoxyeicosatrienoic Acids.
Journal: Basic & clinical pharmacology & toxicology
Published: June 23, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026